ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Outcomes of Live Kidney Donors Who Develop End Stage Renal Disease

A. Muzaale, A. Massie, L. Kucirka, D. Segev.

Johns Hopkins, Baltimore.

Meeting: 2015 American Transplant Congress

Abstract number: 467

Keywords: Donation, Graft failure, Kidney transplantation, Waiting lists

Session Information

Session Name: Concurrent Session: Kidney: Living Donor Issues III

Session Type: Concurrent Session

Date: Tuesday, May 5, 2015

Session Time: 4:00pm-5:30pm

 Presentation Time: 5:12pm-5:24pm

Location: Terrace I-III

Kidney donors can develop ESRD after donation, but the outcomes of those who do remain poorly characterized.

Methods: Using USRDS and SRTR data, we compared access to kidney transplantation (KT), time from ESRD to listing, time from listing to KT, and post-KT graft failure and death between donors and matched nondonors with ESRD.

Results: Among 99 individuals who donated a kidney between April 1994 and November 2011 and who developed ESRD, 78 initially received dialysis (of whom 37 listed for KT, 2 received live donor KT without listing, and 39 never listed for or received a KT), 20 listed preemptively (of whom 19 were subsequently transplanted), and 1 received a preemptive live donor KT without listing or ever receiving dialysis (Figure 1). Donors were listed earlier (median-time-to-listing 17 months versus 120 for nondonors; p<0.001), received KT earlier (median-waiting-time 2.8 months versus 21.5 for nondonors; p<0.001) (Figure 2), and received 13% live donor, 87% standard criteria, and 0% expanded criteria deceased donor KT (versus 39%, 50%, and 11% in nondonors). Post-KT graft (HR 1.1, p=0.7) and patient (HR 0.6, p=0.5) survival were comparable in donors and matched nondonors.

Conclusions: Live donors who developed ESRD were listed and transplanted faster than their matched nondonor counterparts, with equivalent post-transplant outcomes. However, our finding that 39% of donors who developed ESRD never listed for a transplant is tragic and strongly warrants improvements in access to transplantation for such donors.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

To cite this abstract in AMA style:

Muzaale A, Massie A, Kucirka L, Segev D. Outcomes of Live Kidney Donors Who Develop End Stage Renal Disease [abstract]. Am J Transplant. 2015; 15 (suppl 3). https://atcmeetingabstracts.com/abstract/outcomes-of-live-kidney-donors-who-develop-end-stage-renal-disease/. Accessed May 17, 2025.

« Back to 2015 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences